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Abstract
Phthalate esters are man-made chemicals commonly used as plasticizers and solvents, and humans 
may be exposed through ingestion, inhalation, and dermal absorption. Little is known about 
predictors of phthalate exposure, particularly in Asian countries. Because phthalates are rapidly 
metabolized and excreted from the body following exposure, it is important to evaluate whether 
phthalate metabolites measured at a single point in time can reliably rank exposures to phthalates 
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over a period of time. We examined the concentrations and predictors of phthalate metabolite 
concentrations among 50 middle-aged women and 50 men from two Shanghai cohorts, enrolled in 
1997-2000 and 2002-2006, respectively. We assessed the reproducibility of urinary concentrations 
of phthalate metabolites in three spot samples per participant taken several years apart (mean 
interval between first and third sample was 7.5 years [women] or 2.9 years [men]), using 
Spearman's rank correlation coefficients and intra-class correlation coefficients. We detected ten 
phthalate metabolites in at least 50% of individuals for two or more samples. Participant sex, age, 
menopausal status, education, income, body mass index, consumption of bottled water, recent 
intake of medication, and time of day of collection of the urine sample were associated with 
concentrations of certain phthalate metabolites. The reproducibility of an individual's urinary 
concentration of phthalate metabolites across several years was low, with all intra-class correlation 
coefficients and most Spearman rank correlation coefficients ≤ 0.3. Only mono(2-ethylhexyl) 
phthalate, a metabolite of di(2-ethylhexyl)phthalate, had a Spearman rank correlation coefficient ≥ 
0.4 among men, suggesting moderate reproducibility. These findings suggest that a single spot 
urine sample is not sufficient to rank exposures to phthalates over several years in an adult urban 
Chinese population.
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1. Introduction
Phthalate esters are man-made chemicals used as plasticizers and solvents in a variety of 
consumer products, and human exposure is widespread (Guo and others 2011; Silva and 
others 2004; Wittassek and others 2007). Sources of phthalate exposure may include 
contaminated food and drinking water, personal care products, building materials and indoor 
air, as well as certain medications and medical devices (Autian 1973; Duty and others 2005; 
Guo and Kannan 2011; Guo and others 2013; Guo and others 2012; Kelley and others 2012; 
Wormuth and others 2006). Moreover, sources and predictors of exposure may vary 
between populations and geographic areas, and few studies have examined predictors of 
exposure in Asian populations (Guo and others 2011).
The widespread exposure of humans to phthalates is of concern because adverse health 
effects have been reported in animal studies, including endocrine disruption (Wakui and 
others 2013) and reproductive and developmental toxicity (Ahmad and others 2013; 
Martino-Andrade and Chahoud 2010). Human epidemiologic studies have reported 
associations of phthalate exposure with asthma and allergic symptoms and with diabetes in 
adults (Kuo and others 2013; North and others 2014), as well as with altered 
neurodevelopment and genital development in children (Braun and others 2013; Miodovnik 
and others 2014).
Measurement of phthalates exposure in humans is complicated by the rapid metabolism and 
excretion of these compounds. For example, after 24 hours, 67% of an oral dose of di(2-
ethylhexyl) phthalate (DEHP1) is excreted as five major metabolites in urine (Koch and 
others 2006). Previous studies have therefore typically quantified the urinary concentrations 
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of monoester metabolites of phthalates to characterize recent exposure (Anderson and others 
2001; Koch and Calafat 2009). In epidemiologic studies of diseases with long latency 
periods, including cancer, the relevant window of exposure may be many years prior to 
diagnosis. It is therefore important to know how well a single measurement of urinary 
phthalate metabolites may characterize typical exposures over time. Temporal variability in 
individual concentrations of urinary phthalate metabolites may be caused by changes in 
individual behaviors, such as dietary patterns or the use of personal care products, as well as 
by changes in the composition of commercial products, and consequently the presence of 
phthalates in indoor and outdoor environments.
Previous studies have evaluated the intra-individual variability of urinary phthalate 
metabolite measurements, but have generally used repeated samples taken over a relatively 
short period of time, i.e. days or weeks to months (Baird and others 2010; Frederiksen and 
others 2013; Hoppin and others 2002; Meeker and others 2012; Peck and others 2010; Preau 
and others 2010). One recent study reported intra-individual variability in urinary phthalate 
metabolites over a 1 to 3 year period among U.S. women enrolled in the Nurses' Health 
Study (Townsend and others 2013). Our study examines intra-individual variability among 
men and women over a longer period of time (approximately 2 to 8 years) in order to inform 
studies of possible environmental factors contributing to diseases with long latency periods. 
Moreover, most previous studies have been conducted in U.S. and European populations. If 
the sources of exposure to phthalates differ between geographic regions, the temporal 
variability in measured urinary concentrations of phthalate metabolites may also differ. The 
aim of the present study was to estimate the predictors of urinary phthalate metabolite 
concentrations and their intra-individual variability over several years in an adult urban 
Chinese population.
2. Materials and Methods
2.1 Study Population
The 100 participants in this study were residents of urban Shanghai and were enrolled in one 
of two population-based cohort studies: the Shanghai Women's Health Study (SWHS; 
N=74,942; enrollment 1997-2000) or the Shanghai Men's Health Study (SMHS; N=61,582; 
enrollment 2002-2006). Details of the recruitment and eligibility for the parent cohorts have 
been reported previously (Cai and others 2007; Zheng and others 2005). The SWHS 
recruited women aged 40-70 and the participation rate was 92.7% (Zheng and others 2005). 
The SMHS recruited men aged 40-74 and the participation rate was 74.1% (Cai and others 
2007). From these two cohorts, 1,101 individuals were randomly selected and invited to 
participate in a physical activity substudy in 2005-2008 and 56% of those agreed (N=619) 
(Peters and others 2010). Among participants in the physical activity substudy, 50 male and 
1Abbreviations: BMI, body mass index; BzBP, benzylbutyl phthalate; CI, confidence interval; DBP, dibutyl phthalate; DEHP, di(2-
ethylhexyl) phthalate; DEP, diethyl phthalate; DiBP, di-isobutyl phthalate;; HMWP, high molecular weight phthalate; ICC, intra-class 
correlation coefficient; LMWP, low molecular weight phthalate; LOD, limit of detection; MBP, mono-n-butyl phthalate; MiBP, 
mono-isobutyl phthalate; MEP, monoethyl phthalate; MBzP, monobenzyl phthalate; MCNP, mono(carboxynonyl) phthalate; MCOP, 
mono(carboxyoctyl) phthalate; MCPP, mono(3-carboxypropyl) phthalate; MECPP, mono(2-ethyl-5-carboxypentyl) phthalate; 
MEHHP, mono(2-ethyl-5-hydroxyhexyl) phthalate; MEHP, mono(2-ethylhexyl) phthalate; MEOHP, mono(2-ethyl-5-oxohexyl) 
phthalate; NHANES, National Health and Nutrition Examination Survey; SMHS, Shanghai Men's Health Study; SWHS, Shanghai 
Women's Health Study.
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50 female participants were randomly selected within strata of age and year of enrollment 
for urinary phthalate metabolite measurement in the present study. This study was approved 
by the Institutional Review Boards of the participating research institutions. The 
participation of the Centers for Disease Control and Prevention (CDC) laboratory was 
determined not to constitute human subjects research.
2.2 Questionnaires
At the time of enrollment in the SWHS, women completed a self-administered questionnaire 
that elicited information on their health history and demographic characteristics. The 
questionnaire was followed within 2-3 days by an in-person interview to collect additional 
information about smoking, physical activity and other lifestyle variables. Men enrolled in 
the SMHS participated in an in-person interview to collect similar information. Additionally, 
a brief interview was conducted with both men and women at the time of the first urine 
sample collection which elicited information on prescription medication use in the 24 hours 
prior to the collection. Weight was measured at enrollment and again between the second 
and third urine sample collections.
2.3 Urine Samples
Participants (88% of women and 89% of men) provided first urine samples at the time of 
initial enrollment in the parent cohort. A physical activity substudy was conducted within 
the parent cohorts in 2006-2007 and 86% of participants in the substudy provided two 
additional urine samples, for a total of three samples. The second urine sample was collected 
an average of 6.7 years (standard deviation [SD]: 0.7 years) after the first sample for 
women, and 2.2 years (SD: 0.3 years) for men. The third sample was collected 
approximately 9 months after the second sample for both sexes (SD: 1 month). Urine 
specimens were collected in sterilized polypropylene cups containing 125 mg of ascorbic 
acid. Samples were stored on ice until processed within 6 hours of collection, and were 
subsequently maintained at -70 to -80 °C.
2.4 Laboratory Analyses
From each of the three stored urine samples per participant, a 750 microliter aliquot was 
packed on dry ice and shipped overnight to the CDC in Atlanta, GA. Ten blinded, pooled 
quality control samples were also included along with the subject samples. Eleven phthalate 
metabolites were measured using previously published laboratory methods (Kato and others 
2005; Silva and others 2008): mono-n-butyl phthalate (MBP), mono-isobutyl phthalate 
(MiBP), monoethyl phthalate (MEP), monobenzyl phthalate (MBzP), mono(carboxynonyl) 
phthalate (MCNP), mono(carboxyoctyl) phthalate (MCOP), mono(3-carboxypropyl) 
phthalate (MCPP), mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-ethyl-5-
hydroxyhexyl) phthalate (MEHHP), mono(2-ethylhexyl) phthalate (MEHP), mono(2-
ethyl-5-oxohexyl) phthalate (MEOHP). The limits of detection (LOD) were as follows: 0.4 
μg/L (MBP, MEP), 0.2 μg/L (MBzP, MCNP, MCOP, MCPP, MECPP, MEHHP, MEOHP, 
MiBP), 0.5 μg/L (MEHP). For two of the phthalate metabolites a correction factor was 
applied to the measured values (0.72 for MBzP and 0.66 for MEP) in order to adjust for 
detected impurities in laboratory standards, as recommended by the CDC laboratory (CDC 
2012). All three urine samples from each individual were analyzed in the same batch. Inter-
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batch coefficients of variation were calculated for each metabolite and ranged from 2.4% for 
MBP (geometric mean of pooled quality control samples: 51.4 μg/L) to 19.1% for MEHP 
(geometric mean of pooled quality control samples: 3.2 μg/L). As expected, coefficients of 
variation were generally higher for phthalate metabolites present at lower concentrations.
Urinary creatinine was measured at the CDC on a Roche Hitachi Mod P Chemistry Analyzer 
(Roche, Basel, Switzerland) using the enzymatic method described in Roche's Creatinine 
Plus Product Application # 11775685216 V17. Quality control pools representing a range of 
creatinine concentrations were analyzed along with the study samples, and were evaluated 
using standard statistical probability rules. The LOD of the creatinine assay was 3.5 mg/dL.
2.5 Statistical Analyses
Urinary concentrations of phthalate metabolites (μg/L) were divided by the concentration of 
urinary creatinine (g/L) to produce values adjusted for urine dilution (in μg/g creatinine). 
Samples with measured creatinine concentrations ≤20 mg/dL or ≥ 275 mg/dL were excluded 
from analyses (n=4). Among the first urine samples, two samples from men (creatinine ≤20 
mg/dL) and one sample from a woman (creatinine ≥275 mg/dL) were excluded. Among the 
second urine samples, one sample from a woman was excluded due to creatinine ≤20 
mg/dL. No samples were excluded from the third urine sample collection. Because mean 
creatinine differed between men and women, women's creatinine was standardized to the 
distribution of men's creatinine for analyses in which both sexes were pooled together. Some 
analyses were limited to metabolites with detectable concentrations in at least 50% of 
samples. Additional exposure variables were defined as the molar sum of related phthalate 
metabolites. The concentrations (nmol/L) of low molecular weight phthalate (LMWP) 
metabolites MBP, MEP, MiBP were summed to produce the variable ΣLMWP. The 
concentrations of high molecular weight phthalate (HMWP) metabolites MBzP, MCNP, 
MCOP, MECPP, MEHHP, MEHP, and MEOHP were summed to produce the variable 
ΣHMWP. The variable ΣDEHP was defined as the sum of the metabolites MECPP, 
MEHHP, MEHP, and MEOHP. The variable ΣDBP was defined as the sum of MBP and 
MiBP.
Phthalate metabolite concentrations below the LOD were replaced with the LOD divided by 
√2. For statistical tests requiring a normal distribution, phthalate metabolite concentrations 
were natural-log transformed. The Satterthwaite t-test was used to evaluate differences in 
mean concentrations of phthalate metabolites between categories of binary predictor 
variables. Dose-response relationships with log-transformed phthalate metabolite 
concentrations were evaluated using least squares regression for each of the following 
continuous variables: age, income, education and body mass index (BMI). Education was 
entered in dose-response models as a continuous value corresponding to the estimated years 
of schooling completed (no formal education, 0; elementary school, 5; junior high school, 9; 
high school, 12; professional high education, 14; college or above, 16). For income, the 
midpoint of each reported category (or the lower bound plus 1/3 of the lower bound for the 
highest category) was assigned as a continuous value for the purpose of this analysis.
Intra-individual reproducibility of phthalate metabolite concentrations over time was 
evaluated using two methods: the intra-class correlation coefficient (ICC) and Spearman's 
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rank correlation coefficient. Reproducibility was assessed separately for men and women. 
For each metabolite, ICCs were calculated for the variability among the log-transformed 
sample 1, sample 2 and sample 3 concentrations (or log-transformed molar sums of 
concentrations). While random effects models have been previously recommended for 
certain ICC calculations, in our data the within-subject variation in the repeated 
measurements was larger than the between-subject variation for some phthalate metabolites, 
leading to non-identifiability of the variance terms during the estimation process. Therefore, 
we employed an alternative method using the INTRACC macro by Robert Hamer (http://
support.sas.com/kb/25/031.html). The ICCs were calculated using general linear models 
with fixed effects of individual subject and sampling round. The method yields an unbiased 
estimator, which may occasionally produce negative estimates of the non-negative ICC 
value (Rao and Subrahmaniam 1971). For any negative ICC estimates produced, the 
estimated value was replaced by the arbitrary non-negative value 0.01. Confidence intervals 
were generated using Shrout and Fleiss's method (Shrout and Fleiss 1979).
Spearman correlation coefficients were calculated between the first sample urinary phthalate 
metabolite concentrations and the average of the second and third sample concentrations. 
The average of the second and third sample concentrations was used because the time 
elapsed between these samples was relatively short compared to the time elapsed since the 
collection of the first sample, and the average is likely to provide a better estimate of typical 
exposure during the later period. A sensitivity analysis was performed by restricting to 
samples collected in the morning only. Additionally, we performed supplemental analyses 
examining the Spearman correlation coefficients and ICCs between second and third sample 
concentrations. All analyses were performed using SAS 9.3 (SAS Institute, Cary, NC).
3. Results
3.1 Characteristics of study participants
Characteristics of the study participants (Table 1) resembled those of the full cohorts of men 
(Cai and others 2007) and women (Zheng and others 2005). Men were, on average, older 
than women, with mean ages at enrollment of 56 years (men) and 50 years (women). A 
higher proportion of women (22%) than men (10%) had completed elementary school only 
or had no formal education. Men reported a much higher proportion of current smokers 
(62%) than did women (4%). None of the women were pregnant at enrollment.
3.2 Urinary phthalate metabolite concentrations
The average time elapsed between the first and third urine sample was 5.2 years (SD: 2.4 
years, range: 2.5 to 8.3 years), and was shorter for men (2.9 years, SD: 0.3 years, range: 2.5 
to 3.9 years) than for women (7.5 years, SD: 0.7 years, range: 4.8 to 8.3 years). Among the 
first urine samples, approximately two thirds were collected in the afternoon; nearly all other 
samples were collected in the morning (94% of second and 97% of third samples).
The following nine phthalate metabolites were detected in at least 50% of individuals at the 
three sampling times (Table 2): MBP, MiBP, MEP, MBzP, MCPP, MECPP, MEHHP, 
MEHP and MEOHP. Additionally, MCOP was detectable in the majority of men for all 
three rounds of sampling, and in the majority of women for the second and third samples, 
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but was detectable in only 32.7% of women for the first sample. MCNP was detectable in 
less than 50% of samples from each sex and round of sampling.
Among men, the creatinine-adjusted geometric mean concentrations of most phthalate 
metabolites were relatively similar between the first and third samples, although there were 
decreases of at least 25% for MBP, MBzP and MCPP, and decreases of 20-30% in ΣLMWP 
and ΣDBP (Table 2). There was an increase of greater than 50% in the creatinine-adjusted 
geometric mean concentration of MCOP between the first and third samples among men. 
There was greater variability over time for some metabolites among women, corresponding 
to a longer average time elapsed between the first and third samples. Among women, there 
were decreases of greater than 50% between the first and third samples of MBP, MBzP, 
MCPP and ΣDBP, and decreases of at least 25% for MiBP, MEP and ΣLMWP.
The creatinine-adjusted urinary concentrations of several phthalate metabolites in these 
samples differed from concentrations in the U.S. general population (National Health and 
Nutrition Examination Survey, NHANES) from comparable years, and there were consistent 
differences for the first and third samples (Table 3). The first and third sample geometric 
mean concentrations of MBP and MiBP were substantially higher in the Shanghai sample 
than in the comparable NHANES samples, while the concentrations of MEP, MBzP, 
MCOP, and MCPP were lower in the Shanghai sample, some by a factor of 10 or more. The 
geometric mean concentrations of DEHP metabolites (MECPP, MEHHP, MEHP and 
MEOHP) were similar between the Shanghai and NHANES populations.
3.3 Predictors of urinary phthalate metabolite concentrations
The creatinine-adjusted geometric mean urinary concentrations of phthalate metabolites 
were related to a number of demographic and lifestyle characteristics. Some predictors 
differed between the first (Table 4) and third samples (Table 5). In the first sample, the mean 
concentration of MEP was higher among women, while MCOP was higher among men 
(Table 4). By contrast, in the third urine sample, the mean concentrations of MBP, MiBP, 
MCPP, and MECPP were higher among men, and the sex difference in MEP was no longer 
significant (Table 5).
Age as a binary variable was associated with first sample concentrations of MEHP and 
MCPP, such that individuals aged 50 and younger had significantly higher concentrations. 
Age as a continuous variable showed significant inverse linear associations with MEHP 
concentrations in both the first sample (β= -0.03, p=0.02) and the third sample (β= -0.03, 
p=0.04). Age less than or equal to 57 (the median age at third sample collection) was 
associated with higher third sample concentrations of MCOP and MEHP. Post-menopausal 
status in women was associated with lower first sample concentrations of DEHP 
metabolites. We did not examine associations with menopausal status using third sample 
concentrations because only three women remained pre-menopausal at the time of the third 
sample.
Socioeconomic variables were predictive of urinary concentrations of certain phthalate 
metabolites. The level of education completed was not significantly associated with the first 
or third sample concentrations of any phthalate metabolites when considered as a binary 
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variable (greater than middle school vs. less than or equal to middle school). However, years 
of education treated as a continuous variable showed a positive linear association with 
urinary concentrations of MBP (β=0.03, p=0.03), MiBP (β=0.05, p=0.01) and MEHP 
(β=0.06, p=0.03) in the third sample only. Low income was associated with higher first 
sample concentration of MCOP, and income as a continuous variable showed an inverse 
linear association with MCOP in the first sample (β= -0.0003, p=0.04). For third sample 
concentrations of phthalate metabolites, there were no significant associations with income.
A BMI at enrollment of less than 25 kg/m3 was associated with higher first sample 
concentrations of DEHP metabolites, and BMI as a continuous variable was inversely 
associated with first sample concentration of MEHP (β= -0.08, p=0.06). Third sample 
concentrations of MBP and MCPP were higher among those with BMI less than 25 kg/m3 
and there were inverse linear associations between continuous BMI and third sample 
concentrations of MBP (β= -0.06, p=0.004), MBzP (β= -0.09, p=0.01), and MEHP (β= -0.08, 
p=0.046). Current versus former/never smoking among men was not associated with 
concentrations of any phthalate metabolite in either first or third samples, nor was smoking 
at least 13 cigarettes per day among male smokers. Consumption of bottled water among 
women (which largely refers to water in glass carafes rather than plastic bottles) was not 
associated with any phthalate metabolites in the first sample; however, third sample 
concentrations of certain DEHP metabolites (MECPP, MEHHP, MEOHP) were higher 
among women who did not consume bottled water.
Self-reported intake of medication in the 24 hours prior to the first urine sample collection 
was associated with lower concentrations of MBP and MiBP. Recent intake of medication 
was not assessed for the third sample collection. Urine collection in the afternoon was 
associated with higher first sample concentration of ΣLMWP as well as higher 
concentration of MEHP (although this difference was non-significant). This comparison was 
not made for third samples because most samples were collected in the morning.
3.4 Reproducibility of measured urinary phthalate metabolite concentrations over time
The reproducibility of an individual's urinary concentration of phthalate metabolites over 
several years was assessed in two ways (Table 6). The ICC was used to compare the 
variation within individuals to the variation between individuals (based on all three sampling 
rounds for both). ICCs were low for all metabolites; there were no ICC values above 0.3 
among men and none above 0.2 among women. The Spearman's rank correlation coefficient 
was used to assess the consistency of the relative rank ordering of individual phthalate 
concentrations from the first measurement to the average of the second and third 
measurements. Among men, only one phthalate metabolite, MEHP, had a Spearman 
correlation coefficient greater than 0.4 (Spearman correlation coefficients for the other 
DEHP metabolites ranged from 0.21-0.26). Among women, Spearman correlation 
coefficients were lower, and none of the metabolites had a Spearman correlation coefficient 
above 0.3. Results did not change substantially when analyses were restricted to samples 
collected in the morning only, but the sample sizes were limited (17 males and 12 females; 
not shown).
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Reproducibility of urinary phthalate metabolite concentrations between samples 2 and 3, 
collected approximately 9 months apart (mean time interval: 0.8 years, SD: 0.1 years for 
both men and women), was higher than reproducibility between first and third samples for 
certain metabolites (Supplemental Table 1). Among men, MBP and MBzP had ICCs greater 
than 0.5. Among women, MiBP and MEP had ICCs greater than 0.4.
4. Discussion
This study reports on the predictors and reproducibility of urinary phthalate metabolite 
concentrations in a predominantly middle-aged population from urban Shanghai, over a 
period of approximately 2 to 8 years. The concentrations of several phthalate metabolites in 
this population differed from the concentrations measured in the U.S. (NHANES) 
population of comparable years, suggesting different sources or magnitudes of exposure to 
certain phthalates. Specifically, concentrations of LMWPs MBP and MiBP were higher in 
the Shanghai population. Both MBP and MiBP are metabolites of low-molecular weight 
dibutyl phthalates (DBP); MBP may also be derived from exposure to benzylbutyl phthalate 
(BzBP), of which the primary metabolite is MBzP (CDC 2009). We observed lower urinary 
concentrations of MEP (the main metabolite of diethyl phthalate [DEP]), MBzP, MCOP (a 
metabolite of di-isononyl phthalate), and MCPP (a non-specific metabolite of several 
HMWPs and a minor metabolite of DBP) than in the comparable years of NHANES. These 
differences may reflect the different phthalate content of food and personal care products 
used in the U.S. and China.
The products primarily responsible for exposure to phthalates in the general population may 
vary between populations and geographic areas. Inhalation of indoor and outdoor air and 
dermal absorption from personal care products are believed to be the major sources of 
exposure to LMWPs, while dietary intake is primarily responsible for exposure to HMWPs 
such as DEHP (Koch and others 2013; Wormuth and others 2006). A recent study of food 
products from China found DBP in greater than 60% of food samples tested, along with 
dimethyl phthalate, DEP, di-isobutyl phthalate (DiBP), BzBP, and DEHP (Guo and others 
2012), but the study concluded that dietary exposures likely only accounted for less than 
10% of total exposure to DBP in China. Use of personal care products may also be a major 
source of exposure to phthalates in China. In another study, DEP was found in over 50% of 
lotions, shampoos, cleansers and other personal care products purchased from Chinese 
supermarkets in 2012, and DBP, DiBP and DEHP were also commonly detected (Guo and 
others 2013). In the case of DEP, dermal absorption from personal care products may be 
responsible for a large fraction of daily exposure (Guo and others 2013).
Dietary intake is believed to account for a large proportion of exposure to DEHP in China, 
as in European countries and the USA (Guo and others 2013; Rudel and others 2011). 
MEHP, MEOHP, MEHHP, and MECPP are all metabolites of DEHP, and were present in 
the Shanghai population at concentrations comparable to those reported in NHANES 
participants' samples from comparable years. Dietary predictors of exposure in this 
population, however, were beyond the scope of this study.
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The concentrations of several urinary phthalate metabolites declined between the first and 
third samples. These decreases were most pronounced among women, which corresponds 
with the longer average time elapsed between the first and third sample collections in 
women (7.5 years) as compared to men (2.9 years). Phthalate metabolites which showed 
notable declines over time among women included LMWPs (MEP, MBP, and MiBP), as 
well as MBzP and MCPP. Given that the principal source of exposure to LMWPs is thought 
to be non-food products, exposure through personal care products and other consumer 
products may have declined between 1997 and 2006, either through changes in usage 
patterns or changes in the compositions of these products. There were also decreases in the 
geometric mean concentrations of ΣLMWP and ΣDBP among men, corresponding to the 
period between 2002 and 2006. Temporal trends in exposure to several phthalates, both 
LMWPs and HMWPs, have been also reported among the US and German general 
populations (Wittassek and others 2007; Zota and others 2014).
Predictors of urinary phthalate metabolite concentrations included sex, age, education, 
income, BMI, menopausal status, recent intake of medications, consumption of bottled 
water, and time of day of urine sample collection. In the third sampling round, MBP, MiBP, 
MCPP and MECPP were higher among men than women, despite standardization of female 
creatinine concentrations to the male creatinine distribution in this population. Sex 
differences in LMWPs may reflect different dietary intake or other sources of exposure. 
Certain metabolites —MEHP and MCPP in the first sample, and MEHP and MCOP in the 
third sample—were inversely related with age, which may reflect differences in dietary 
patterns between older and younger individuals, or other unidentified sources of exposure. 
First sample concentrations of DEHP metabolites were higher among pre-menopausal 
women than among post-menopausal women.
BMI at enrollment was inversely associated with concentrations of DEHP metabolites. For 
the third sampling, continuous BMI was inversely associated with concentrations of MBP 
and MBzP, and with MEHP but not with other DEHP metabolites. Previous cross-sectional 
studies have produced varied results. Some have reported positive associations between 
BMI and MBzP (Wolff and others 2008) and MEP (Duty and others 2005; Hatch and others 
2008). In a study of men and women aged 60-80, MBP was inversely associated with BMI 
(Hatch and others 2008), consistent with our third sample finding.
Socioeconomic status may be associated with certain sources of exposure to phthalates. 
Lower income was associated with higher first sample urinary concentration of MCOP. 
Higher levels of education were associated with higher third sample concentrations of MBP, 
MiBP and MEHP. Women who reported drinking bottled water had lower third sample 
concentrations of certain DEHP metabolites, suggesting that bottled water intake among 
women in Shanghai (which includes bottled water from glass carafes) may be associated 
with other behaviors or characteristics that reduce exposure to DEHP. Recent medication 
intake (in the 24 hours prior to first urine collection) was associated with lower 
concentrations of ΣDBP. Interestingly, certain LMWP, including DEP and DBP, have been 
used in FDA-approved medications in the United States (Hernández-Díaz and others 2009; 
Kelley and others 2012) and therefore higher concentrations following use of certain 
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medications might be expected. However, the phthalate content of medications used in this 
Shanghai population was unknown.
Overall, the within-individual variability in phthalate metabolites over our study period was 
high relative to the between-individual variability, and the reproducibility across repeated 
samples was low. This is consistent with the relatively rapid excretion of phthalate 
metabolites (Anderson and others 2011; Anderson and others 2001), as well as the likely 
episodic nature of the exposures. Our results suggest that a single spot urine measurement of 
phthalate metabolites will not sufficiently rank phthalate exposures over a period of several 
years in this population. The reproducibility for certain metabolites tended to be higher 
among men than among women, perhaps owing to the different use patterns of products 
responsible for exposure to different phthalates, or to the longer interval between samples 
for women in this study. It is notable, however, that the majority of first urine samples were 
collected in the afternoon, while the majority of second and third urine samples were 
collected in the morning. These differences in timing of collection could lead to 
underestimation of reproducibility, due to daily patterns in personal care product use or 
dietary intake.
Previous studies of the variability and reliability of urinary phthalate metabolites over time 
have examined shorter time intervals than those in our study. Reproducibility in previous 
studies was generally low to moderate, with some exceptions. Low to moderate ICCs 
(0.36-0.65) have been reported for LMWPs over weeks to months (Braun and others 2012; 
Meeker and others 2012; Whyatt and others 2012); the same studies have reported low 
reproducibility for DEHP metabolites (ICCs: 0.08-0.42). Some studies that restricted to first-
morning voids found moderate to high reproducibility, particularly for LMWPs among 
women (ICCs: 0.51-0.80) (Hoppin and others 2002; Peck and others 2010). Reproducibility 
of first-morning DEHP metabolites among women remained low (ICCs: 0.13-0.37) (Baird 
and others 2010; Peck and others 2010). A study collecting both spot and first-morning urine 
samples reported similarly low to moderate ICCs from both types of samples for most 
phthalate metabolites (ICCs: 0.13-0.68 for spot urine, 0.20-0.48 for first-morning urine) 
(Frederiksen and others 2013). Another study of variability over 1 week found high 
reproducibility for MEP (ICC: 0.91) and low reproducibility for MEHHP (ICC: 0.25) among 
several first-morning samples (Preau and others 2010); both metabolites had somewhat 
lower reproducibility among spot samples.
Few studies have examined variability of phthalate metabolites over years rather than days 
to months. One recent study examined reproducibility in urine samples collected over 1-3 
years from U.S. women enrolled in the Nurses' Health Study (Townsend and others 2013). 
Among their samples, most of which were first-morning voids, the reproducibility over time 
was low to moderate for the LMWP metabolites (ICCs: 0.30-0.53), as well as for the DEHP 
metabolites (ICCs: 0.39-0.43) with the exception of MEHP, which was notably lower (ICC: 
0.14) (Townsend and others 2013). In our study, reproducibility of DEHP metabolites 
(ICCs: 0.04-0.20) and LMWPs (ICCs: 0.15-0.30) were poor over several years. Low 
reproducibility in our study may be due to the longer time interval elapsed between samples, 
and possibly to the different and changing sources of exposure in Shanghai over the duration 
of the study. Reproducibility over approximately 9 months between the second and third 
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sampling rounds was low to moderate among LMWPs (ICCs: 0.19-0.64) and remained low 
among DEHP metabolites (ICCs: 0.01-0.23).
Strengths of this study include the unique sample of an urban Chinese population, allowing 
us to identify predictors of phthalate exposure in a relatively understudied group, and the 
long period of time over which the repeated samples were collected, allowing the 
assessment of variability and reproducibility over several years. Limitations include the 
small sample size, especially when stratified by sex, the differences in time of day of 
collection between the first sample and the second and third samples, and the different 
timing of collection between men and women, both in the interval between samples and the 
calendar years of the first collection.
5. Conclusions
The results of our study suggest that a single spot urine measurement is not sufficient to rank 
individuals' usual exposures to phthalates over a period of several years. The within-
individual variability of phthalate metabolite concentrations was high relative to between-
individual variability and the reproducibility was low in both men and women. This finding 
is particularly important for studies of diseases of long latency, such as cancer, when 
researchers would like to assess environmental exposures that may have occurred years 
earlier.
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Highlights
• We identify predictors of urinary phthalate metabolites in an urban Chinese 
cohort.
• The reproducibility of phthalate metabolite concentrations over 2-8 years was 
low.
• A single spot urine sample may be insufficient to rank exposures over years.
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Table 1
Characteristics at enrollmenta of participants randomly selected from the Shanghai Women's and Shanghai 
Men's Health Studies [values are numbers (percentages)].
Characteristic Total (n = 100) Women (n = 50) Men (n = 50)
Age at enrollment
 40-49 40 (40) 27 (54) 13 (26)
 50-59 33 (33) 13 (26) 20 (40)
 60-72 27 (27) 10 (20) 17 (34)
Highest educational level attained
 Elementary school or no formal education 16 (16) 11 (22) 5 (10)
 Middle school 38 (38) 19 (38) 19 (38)
 High school 30 (30) 13 (26) 17 (34)
 Technical school/college or above 16 (16) 7 (14) 9 (18)
Body mass index (kg/m2) at enrollment
 <20 6 (6) 4 (8) 2 (4)
 20-24.99 55 (55) 25 (50) 30 (60)
 25-29.99 34 (34) 17 (34) 17 (34)
 ≥30 5 (5) 4 (8) 1 (2)
Menopausal status
 Premenopausal 26 (52)
 Postmenopausal 23 (46)
 Unknown 1 (2)
Cigarette smoking status
 Current 33 (33) 2 (4) 31 (62)
 Former 4 (4) 0 (0) 4 (8)
 Never 63 (63) 48 (96) 15 (30)
Number of cigarettes smoked per day (among current smokers)
 1-6 3 (9) 2 (100) 1 (3)
 7-12 11 (33) 0 (0) 11 (35)
 13+ 19 (58) 0 (0) 19 (61)
Family income in previous yearb
 “Low” 65 (65) 30 (60) 35 (70)
 “High” 35 (35) 20 (40) 15 (30)
Usual source of drinking waterc
 Tap water only 33 (66)
 Tap water and bottled water 17 (34)
Any medicine taken in past 24 hours
 Yes 59 (59) 28 (56) 31 (62)
 No 41 (41) 22 (44) 19 (38)
Time of day of collection for first urine sample
 7:00am – 8:59am 4 (4) 3 (6) 1 (2)
 9:00am – 11:59am 29 (29) 12 (24) 17 (34)
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Characteristic Total (n = 100) Women (n = 50) Men (n = 50)
 12:00pm – 2:59pm 12 (12) 6 (12) 6 (12)
 3:00pm – 7:59pm 55 (55) 29 (58) 26 (52)
Time of day of collection for second urine sample
 6:00am – 8:59am 71 (71) 38 (76) 33 (66)
 9:00am – 11:59am 23 (23) 8 (16) 15 (30)
 12:00pm – 2:59pm 4 (4) 2 (4) 2 (4)
 3:00pm – 5:59pm 2 (2) 2 (4) 0 (0)
Time of day of collection for third urine sample
 6:00am – 8:59am 66 (66) 32 (64) 34 (68)
 9:00am – 11:59am 31 (31) 17 (34) 14 (28)
 12:00pm – 2:59pm 2 (2) 0 (0) 2 (4)
 3:00pm – 5:59pm 1 (1) 1 (2) 0 (0)
a
Enrollment was in 1997-2000 for women and in 2002-2006 for men.
b
“Low” and “high” annual income were defined using cutpoints of 20,000 yuan for women and 12,000 yuan for men, which represent the 
approximate medians reported by each sex.
c
This information was collected from women only.
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